Allergy Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,300.00$ 8,900.00

Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, and Other Instruments), Services), by Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), Test Type (In Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests), End User (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users) and Geography

 

$ PRICE - $ 3,300.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,300.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Allergy Diagnostics Market Size was valued at USD 4.2 billion in 2021 and is poised to grow at a significant CAGR of 11.3% over 2022–2028. According to the World Health Organization (WHO), 80% or more of people living in cities are exposed to air quality levels higher than those considered safe. Although this is a global trend, its impacts are more severe in the cities of low-income nations. As one of the risk factors for allergic disorders, air pollution from motor vehicles is a significant indicator of the market growth for allergy diagnostics. According to epidemiological and toxicological studies, asthma, allergic rhinitis, and other allergy illnesses are more common when air pollution occurs. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Moreover, reagent rental contracts are sales contracts between manufacturers of allergy diagnostic products and end-users (such as hospitals and diagnostic laboratories). As per these contracts, the manufacturer and the end-user sign a reagent-purchase contract, wherein the end-user leases or purchases instruments at a discounted price. The end user’s initial capital investment is reduced due to this good agreement, which also assures the manufacturer of sales over a significant period. Analyzers may occasionally be hired to customers on a pay-per-test basis. For laboratories looking to cut expenses, reagent rental agreements and cost-per-test contracts are advantageous. Additionally, they assist laboratories in avoiding substantial fixed capital expenses related to acquiring new machinery. These costs are significantly greater for high-volume laboratories than for a typical laboratory. Additionally, as contracts often run between 5 and 10 years, laboratories stay current with advancements in allergy diagnoses. Some warranties also cover service/maintenance costs, which gives laboratories an extra chance to save money. Furthermore, to expand market share, the market players use various techniques, including product launches, partnerships, acquisitions, and expansions.

Recent Market Developments:

In 2021, Hitachi Chemical Diagnostics, Inc. has been renamed Minaris Medical America, Inc. By uniting the medical business group companies under the name of Minaris Medical, Hitachi aims to strengthen its global presence and expand business operations in the field of in-vitro diagnostics. The companies are a part of Showa Denko Materials Co., Ltd. (renamed from Hitachi Chemical Co., Ltd. on Oct 1, 2020).

In 2021, PerkinElmer Inc. entered into an agreement with Immunodiagnostic Systems Holdings PLC to acquire the later. The acquisition will enable PerkinElmer Inc. to strengthen its position in the ImmunoDiagnostics (IDS) market. IDS would be incorporated under EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a company offering allergy products and solutions.

Allergy Diagnostics Market

MARKET SUMMARY
-
11.3% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 11.3%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market–  North America

Allergy Diagnostics Market

  • The global allergy diagnostics market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The allergy diagnostics market report gives historical, current, and future market sizes (US$ Mn) on product & services, allergen, test type, end user, and geography.
Key Players
  • Stallergenes Greer
  • Siemens Healthcare
  • Lincoln Diagnostics
  • Hycor Biomedical
  • Alcon Laboratories
Allergy Diagnostics Market Dynamics

The market for allergy diagnostics is anticipated to grow due to factors including the high prevalence of allergic diseases and their associated high economic burden, rising levels of environmental pollution, increased funding for allergy diagnostics by organizations, and increased access to healthcare insurance. Additionally, allergies are becoming more common in cities. As a result, more primary care doctors are providing or suggesting allergy diagnostics. However, high prices for allergy diagnostic tools are a commercial restraint.


North-America Got Significant Share

Allergy Diagnostics Market

The allergy diagnostics market in North America is likely to hold a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. In line with research from the Asthma and Allergy Foundation of America, allergies are the sixth most common chronic ailment in America, affecting almost 50 million people annually. The demand for quick and accurate allergy diagnostics will increase as medication-related fatalities increase. The prevalence of skin allergies in black Americans, particularly eczema and skin inflammation, as well as the high prevalence of allergic rhinitis (hay fever), will drive the growth of the allergy diagnostics market in the United States. The availability of an advanced healthcare system and rising consumer spending on healthcare will drive the allergy diagnostics market in the United Kingdom during the forecast period. The demand for allergy diagnostics will be fueled by increasing knowledge of allergic reactions such as hay fever, atopic eczema, and asthma in the European region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The allergy diagnostics market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
Allergy Diagnostics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The allergy diagnostics market is projected to expand at a CAGR of 11.3% during the forecast period.

Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group, Alcon Laboratories

North America is the fastest-growing region for allergy diagnostics market


Report

Company Profile

  • bioMerieux
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Omega Diagnostics
  • Hitachi Chemical Diagnostics
  • Stallergenes Greer
  • Siemens Healthcare
  • Lincoln Diagnostics
  • Hycor Biomedical
  • HOB Biotech Group
  • Alcon Laboratories

Description

Allergy Diagnostics Market Size was valued at USD 4.2 billion in 2021 and is poised to grow at a significant CAGR of 11.3% over 2022–2028. According to the World Health Organization (WHO), 80% or more of people living in cities are exposed to air quality levels higher than those considered safe. Although this is a global trend, its impacts are more severe in the cities of low-income nations. As one of the risk factors for allergic disorders, air pollution from motor vehicles is a significant indicator of the market growth for allergy diagnostics. According to epidemiological and toxicological studies, asthma, allergic rhinitis, and other allergy illnesses are more common when air pollution occurs. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Moreover, reagent rental contracts are sales contracts between manufacturers of allergy diagnostic products and end-users (such as hospitals and diagnostic laboratories). As per these contracts, the manufacturer and the end-user sign a reagent-purchase contract, wherein the end-user leases or purchases instruments at a discounted price. The end user’s initial capital investment is reduced due to this good agreement, which also assures the manufacturer of sales over a significant period. Analyzers may occasionally be hired to customers on a pay-per-test basis. For laboratories looking to cut expenses, reagent rental agreements and cost-per-test contracts are advantageous. Additionally, they assist laboratories in avoiding substantial fixed capital expenses related to acquiring new machinery. These costs are significantly greater for high-volume laboratories than for a typical laboratory. Additionally, as contracts often run between 5 and 10 years, laboratories stay current with advancements in allergy diagnoses. Some warranties also cover service/maintenance costs, which gives laboratories an extra chance to save money. Furthermore, to expand market share, the market players use various techniques, including product launches, partnerships, acquisitions, and expansions.

Recent Market Developments:

In 2021, Hitachi Chemical Diagnostics, Inc. has been renamed Minaris Medical America, Inc. By uniting the medical business group companies under the name of Minaris Medical, Hitachi aims to strengthen its global presence and expand business operations in the field of in-vitro diagnostics. The companies are a part of Showa Denko Materials Co., Ltd. (renamed from Hitachi Chemical Co., Ltd. on Oct 1, 2020).

In 2021, PerkinElmer Inc. entered into an agreement with Immunodiagnostic Systems Holdings PLC to acquire the later. The acquisition will enable PerkinElmer Inc. to strengthen its position in the ImmunoDiagnostics (IDS) market. IDS would be incorporated under EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a company offering allergy products and solutions.

Reviews

There are no reviews yet.

Be the first to review “Allergy Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX